Opana ER
-

Malvern-Based Endo Hit with Court-Ordered Penalty for False Marketing
Malvern-based Endo Health Solutions has been ordered to pay over $1.5 billion in criminal financial penalties after the company admitted to falsely marketing Opana ER,…
-

Endo International in Malvern to Pay $465M in Opioid Settlement
Malvern-based Endo International has agreed to pay up to $465 million over several years to settle federal civil and criminal charges over its marketing and…
-

Lawyers, Federal Regulators Critical of Malvern-Based Endo’s Royalties from Drug Opana
Lawyers and federal agencies are arguing that Malvern-based drug maker Endo is still profiting from the disgraced oxymorphone pill also known as Opana ER. Back in…
-

Chester County Briefly: July 10
Gawthrop Greenwood and Volunteer English Program John Rafferty, an attorney with the law firm Gawthrop Greenwood, has been elected to the board of the Volunteer…
-

FDA Asks Malvern’s Endo to Pull Opioid Pain Med from Shelves
The rampant drug abuse linked to a Malvern-based opioid pain medication has led to the U.S. Food and Drug Administration’s first-ever call to pull it…
-

FDA Decides Risks Outweigh Benefits of Endo’s Opioid Painkiller
A Food and Drug Administration panel has found that the benefits no longer outweigh the risks of Endo International’s opioid painkiller, Opana ER, writes John…











































